Clopidogrel in infants with systemic-to-pulmonary-artery shunts

Authors

David L. Wessel, George Washington UniversityFollow
Felix Berger, German Heart Institute Berlin and Charité, Berlin, Germany
Jennifer S. Li, Duke Clinical Research Institute, Durham, NC
Ingo Dahnert, University of Leipzig, Leipzig, Germany
Amit Rakhit, Bristol-Myers Squibb, Princeton, NJ
Sylvie Fontecave, Sanofi Research and Development, Chilly-Mazarin, France
Jane W. Newburger, Harvard University
+573 additional collaborators

Document Type

Journal Article

Publication Date

2013

Journal

New England Journal of Medicine

Volume

Volume 368, Issue 25

Inclusive Pages

2377-2384

Keywords

Heart Defects; Congenital--surgery; Platelet Aggregation Inhibitors--therapeutic use; Thrombosis--prevention & control; Ticlopidine--analogs & derivatives

APA Citation

Wessel, D. L., Berger, F., Li, J. S., Daḧnert, I., Rakhit, A., Fontecave, S., & Newburger, J. W. (2013). Clopidogrel in infants with systemic-to-pulmonary-artery shunts. New England Journal of Medicine, 368(25), 2377-2384.

Peer Reviewed

1